Alchemyca Biotech | $2,500,000 | (Nov 22, 2024)
TailorMed | $40,000,000 | (Nov 22, 2024)
Iontra Inc | $45,000,000 | (Nov 22, 2024)
Turneo
United Kingdom
- London, England
- 24/09/2024
- Seed
- $2,228,640
Stand out from the crowd by curating your own collection of experiences, recommended specially for your guests.
Turneo provides a plug and play solution for innovative hotels and resorts so they can offer incredible in-destination experiences to their guests.
We bring 3 key elements of selling experiences together:
🔎 Guests are able to browse and book all of their holiday activities, directly via your hotel or resort website.
📆 Staff are able to see and manage experience bookings seamlessly, with our intuitive agent tool.
📊 Managers are equipped with the tools they need to understand, build, and grow their experience offer.
The result?
📈 Our partners see up to 20x return on investment, and 18% higher guest satisfaction.
🌟 100% of guests rate our service as easy to book.
With no complex integration and zero setup fee, you can start growing your experience offer in less than a week.
- Industry Technology, Information and Internet
- Website https://www.turneo.com/
- LinkedIn https://www.linkedin.com/company/turneo/
Related People
Matija MarijanCo Founder
United Kingdom -
London, England
CEO & Co-Founder of Turneo - the global experience commerce platform. Turneo enables travel brands to launch experience stores and deliver unforgettable experiences to their guests.
Prior to that, executive at Expedia, part of the leadership team of Expedia's $15bn+ B2B division, responsible for strategy & strategic initiatives. Started career as a strategy consultant at Strategy& / PwC.
Enveda | $130,000,000 | (Nov 22, 2024)
Shinami | $5,645,000 | (Nov 22, 2024)
DANNCE.ai | $2,600,000 | (Nov 22, 2024)
Trustero | $10,000,000 | (Nov 22, 2024)
Dote | $1,447,585 | (Nov 22, 2024)
CredFlow | $3,700,000 | (Nov 22, 2024)
Lighthouse (UK) | $370,000,000 | (Nov 22, 2024)
Faircraft | $15,800,000 | (Nov 22, 2024)
Clean Skin Club | $32,000,000 | (Nov 22, 2024)